查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1420412

全球夜間隱形眼鏡市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按指示、按最終用戶、按地區

Night Contact Lens Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 350 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

預計2024年全球夜間隱形眼鏡市場規模將達9億美元，複合年增長率(CAGR)為10%，呈現強勁成長，預計2031年底將達到17億美元。近視指示佔據市場主導地位，2023 年將佔據 53.6% 的重要市場份額。其中，夜間隱形眼鏡銷售額佔同年全球隱形眼鏡市場總銷售額約5.6%。

角膜塑形術是一種使用特殊隱形眼鏡有意修改角膜前表面的方法，為摘除鏡片後矯正屈光不正提供暫時且不可逆的解決方案。現代 Ortho-K 使用由硬質高透氧材料製成的反向幾何鏡片，過夜佩戴可矯正屈光不正並改變前角膜的形狀。

隨著近視盛行率顯著增加，估計影響全球超過10億人，需要解決和緩解與近視相關的眼科問題。兒童和青少年近視的迅速增加，尤其是在東亞國家，增加了對角膜塑形鏡等創新治療的需求，這種治療可以治療所有年齡層的近視、遠視和散光。

角膜塑形術被認為是一種安全有效的光學矯正方法，因其減少兒童近視以及改善整體視力和生活品質的其他好處而變得流行。早期開始角膜塑形術可以降低低齡近視兒童高度近視的盛行率。

專為夜間配戴 Ortho-K 設計的透氣 (GP) 鏡片比輕度視力處方顯示出更高的成功率。在FDA進行的角膜屈光治療（CRT）和視力矯正治療（VST）鏡片的臨床試驗中，超過65%的ortho-k患者達到了20/20的視力，超過90%的患者達到了20/40或更好. 已經取得了令人印象深刻的視力結果，包括達到 的視力。

該報告研究了全球夜間隱形眼鏡市場，並提供了市場概況，包括按適應症、最終用戶、地區劃分的趨勢以及進入市場的公司的競爭趨勢。

目錄

第一章執行摘要

第二章市場概況

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • COVID-19 影響分析
  • 烏克蘭與俄羅斯衝突的影響
  • 經濟概況
  • PESTLE分析

第三章 2018-2031年全球夜間隱形眼鏡市場前景

  • 2018-2031 年全球夜間隱形眼鏡市場前景（依指標、價值（百萬美元））
  • 全球夜間隱形眼鏡市場前景，按最終用戶劃分，價值（百萬美元），2018-2031
  • 2018-2031 年全球夜間隱形眼鏡市場前景（按地區、價值（百萬美元））

第四章 2018-2031年北美夜間隱形眼鏡市場前景

第5章 2018-2031年歐洲夜間隱形眼鏡市場前景

第六章 2018-2031 年亞太地區夜間隱形眼鏡市場展望

第七章 2018-2031 年拉丁美洲夜間隱形眼鏡市場展望

第8章 2018-2031年中東和非洲夜間隱形眼鏡市場前景

第9章 競爭格局

  • 按產品和最終用戶劃分的熱圖
  • 2023 年公司市場份額分析
  • 比賽儀表板
  • 公司簡介
    • Cooper Vision
    • Euclid Systems
    • Johnson & Johnson
    • Bausch & Lomb
    • Truform Optics
    • Art Optical Contact Lens, Inc.
    • Menicon Co., Ltd./Alpha
    • Brighten Optix
    • Eyebright Medical Technology Beijing Co Ltd
    • Lucid
    • Optact International Ltd.

第10章附錄

簡介目錄

In the year 2024, the global night contact lens market reached a valuation of US$ 900 million and is projected to witness robust growth with a Compound Annual Growth Rate (CAGR) of 10%, ultimately reaching US$ 1700 million by the conclusion of 2031. According to Fairfield Market Research, myopia indication dominated the market, holding a substantial market value share of 53.6% in 2023. Notably, night contact lens sales contributed to around 5.6% of the total revenue share in the global contact lens market during the same year.

Orthokeratology, a method involving the purposeful modification of the anterior cornea using specialized contact lenses, offers a temporary and irreversible solution to eliminate refractive errors post-lens removal. Modern ortho-k employs reverse geometry lenses constructed with hard, highly oxygen-permeable materials to correct refractive errors and reshape the anterior cornea when worn overnight.

Estimates project a considerable increase in myopia prevalence, affecting over 1 billion people globally, necessitating the addressing and mitigation of myopia-related ophthalmic issues. The surge in myopia, particularly among children and teenagers in East Asian countries, has fueled the demand for innovative treatments like ortho-k lenses, which can treat myopia, hyperopia, and astigmatism across all age groups.

Orthokeratology, recognized as a safe and effective method for optical correction, has gained popularity for its additional benefits of reducing childhood myopia and enhancing overall eyesight and quality of life. Early initiation of ortho-k therapy may potentially reduce the prevalence of high myopia in younger myopic children.

Gas permeable (GP) lenses designed for ortho-k, worn overnight, have demonstrated higher success rates than mild vision prescriptions. Clinical trials conducted by the FDA on corneal refractive therapy (CRT) and vision shaping treatment (VST) lenses revealed impressive visual acuity results, with over 65% of ortho-k patients achieving 20/20 vision and more than 90% achieving 20/40 or greater vision.

Market Expansion Strategies for Night Contact Lens Manufacturers:

Better Alternative than Laser Vision Correction (LASIK)

While laser corrective surgery offers a long-term solution for vision issues, it comes with potential risks such as severe dry eye, impaired vision, and infections. In contrast, ortho-k presents a safer alternative without side effects, approved by the FDA for both children and adults. Recent advancements in ortho-k designs, like MOONLENS and REMlens, have improved myopia control, and ongoing research explores its potential as a permanent myopia treatment.

Ortho-k lenses, being a cost-effective alternative to laser surgery, offer clear vision during the day without compromising corneal integrity. Athletes and sports enthusiasts find them particularly appealing for their all-day clear vision without the need for prescription lenses or glasses, enhancing their overall experience.

Challenges and Considerations in Night Contact Lens Market Expansion:

Lack of Availability of Long-term Data

While ortho-k provides short-term benefits, it is not without risks and adverse effects similar to standard soft contact lenses. Regular follow-ups and aftercare visits are essential, making it a time-consuming process. The small size and transparency of ortho-k lenses pose challenges, especially for children, who may easily lose them. Additionally, wearing night contact lenses every night to maintain corneal shape can be tedious, and success in slowing down myopia progression is not guaranteed.

Country-wise Market Insights:

U.S. Market: Vision-Associated Issues on the Rise

The U.S. remains the dominant player in the North American market. Research indicates a significant prevalence of vision impairments among Americans, with a substantial portion using contact lenses. Prolonged screen time, particularly among individuals aged 16 to 25, is contributing to the growing issue of vision problems, underscoring the demand for effective solutions such as night contact lenses.

Germany Market: Technology Advancements Drive Growth

Germany holds a substantial share of the European market, with a promising outlook driven by advancements in ortho-k technology. Eye care manufacturers based in Germany are expanding their reach globally, introducing innovative products to meet the increasing demand for ortho-k lenses.

China Market: Surge in Clinical Trials and Studies

China maintains its dominant position in the East Asia market. Numerous ortho-K manufacturers, including Paragon, Lucid, Euclid, and ProCornea, operate in China. The presence of well-established lens companies like Bausch+Lomb and Cooper Vision, along with a notable increase in clinical trials, solidifies China's status as a significant player in the global night contact lens market.

Competitive Analysis:

Leading manufacturers are introducing innovative products to expand their global market presence.

Key Companies Profiled:

  • Cooper Vision
  • Euclid Systems
  • Johnson & Johnson
  • Bausch & Lomb
  • Truform Optics
  • Art Optical Contact Lens, Inc.
  • Menicon Co., Ltd. Alpha
  • Brighten Optix
  • Eyebright Medical Technology Beijing Co Ltd
  • Lucid
  • Optact International Ltd.
  • Taiwan Macro Vision Corporation
  • E & E optics
  • GP Specialists
  • MiracLens L.L.C.
  • Laboratoire LCS
  • Multilens AB
  • Falco lenses AG
  • EIKON
  • Biolens Lab

Key Segments of Night Contact Lens Industry Research

By Indication:

  • Myopia
  • Astigmatism
  • Hyperopia
  • Presbyopia

By End User:

  • Hospitals
  • Ophthalmology Clinics
  • Vision Care Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Night Contact Lens Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Night Contact Lens Market Outlook, 2018 - 2031

  • 3.1. Global Night Contact Lens Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Myopia
      • 3.1.1.2. Astigmatism
      • 3.1.1.3. Hyperopia
      • 3.1.1.4. Presbyopia
  • 3.2. Global Night Contact Lens Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Hospitals
      • 3.2.1.2. Ophthalmology Clinics
      • 3.2.1.3. Vision Care Centers
  • 3.3. Global Night Contact Lens Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Night Contact Lens Market Outlook, 2018 - 2031

  • 4.1. North America Night Contact Lens Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Myopia
      • 4.1.1.2. Astigmatism
      • 4.1.1.3. Hyperopia
      • 4.1.1.4. Presbyopia
  • 4.2. North America Night Contact Lens Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Hospitals
      • 4.2.1.2. Ophthalmology Clinics
      • 4.2.1.3. Vision Care Centers
  • 4.3. North America Night Contact Lens Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 4.3.1.2. U.S. Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 4.3.1.3. Canada Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 4.3.1.4. Canada Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Night Contact Lens Market Outlook, 2018 - 2031

  • 5.1. Europe Night Contact Lens Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Myopia
      • 5.1.1.2. Astigmatism
      • 5.1.1.3. Hyperopia
      • 5.1.1.4. Presbyopia
  • 5.2. Europe Night Contact Lens Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Hospitals
      • 5.2.1.2. Ophthalmology Clinics
      • 5.2.1.3. Vision Care Centers
  • 5.3. Europe Night Contact Lens Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.3.1.2. Germany Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.3. U.K. Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.3.1.4. U.K. Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.5. France Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.3.1.6. France Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.7. Italy Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.3.1.8. Italy Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.9. Turkey Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.3.1.10. Turkey Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.11. Russia Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.3.1.12. Russia Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.13. Rest of Europe Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.3.1.14. Rest of Europe Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Night Contact Lens Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Night Contact Lens Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Myopia
      • 6.1.1.2. Astigmatism
      • 6.1.1.3. Hyperopia
      • 6.1.1.4. Presbyopia
  • 6.2. Asia Pacific Night Contact Lens Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Hospitals
      • 6.2.1.2. Ophthalmology Clinics
      • 6.2.1.3. Vision Care Centers
    • 6.2.2. BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Night Contact Lens Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.3.1.2. China Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.3. Japan Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.3.1.4. Japan Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.5. South Korea Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.3.1.6. South Korea Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.7. India Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.3.1.8. India Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.9. Southeast Asia Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.3.1.10. Southeast Asia Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Night Contact Lens Market Outlook, 2018 - 2031

  • 7.1. Latin America Night Contact Lens Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Myopia
      • 7.1.1.2. Astigmatism
      • 7.1.1.3. Hyperopia
      • 7.1.1.4. Presbyopia
  • 7.2. Latin America Night Contact Lens Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
      • 7.2.1.1. Hospitals
      • 7.2.1.2. Ophthalmology Clinics
      • 7.2.1.3. Vision Care Centers
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Night Contact Lens Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 7.3.1.2. Brazil Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.3.1.3. Mexico Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 7.3.1.4. Mexico Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.3.1.5. Argentina Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 7.3.1.6. Argentina Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Night Contact Lens Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Night Contact Lens Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Myopia
      • 8.1.1.2. Astigmatism
      • 8.1.1.3. Hyperopia
      • 8.1.1.4. Presbyopia
  • 8.2. Middle East & Africa Night Contact Lens Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Hospitals
      • 8.2.1.2. Ophthalmology Clinics
      • 8.2.1.3. Vision Care Centers
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Night Contact Lens Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 8.3.1.2. GCC Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.3.1.3. South Africa Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 8.3.1.4. South Africa Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.3.1.5. Egypt Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 8.3.1.6. Egypt Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.3.1.7. Nigeria Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 8.3.1.8. Nigeria Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By Product vs by End User Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Cooper Vision
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Therapy Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Euclid Systems
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Therapy Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Johnson & Johnson
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Therapy Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Bausch & Lomb
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Therapy Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Truform Optics
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Therapy Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Art Optical Contact Lens, Inc.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Therapy Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Menicon Co., Ltd./ Alpha
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Therapy Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Brighten Optix
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Therapy Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Eyebright Medical Technology Beijing Co Ltd
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Therapy Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Lucid
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Therapy Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. Optact International Ltd.
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Therapy Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations